Global Bio Forum 2020



About Medical Korea Brand Launch Ceremony & Symposium

The Global Bio Forum 2020 is organized by News1 Korea with the objective to share global trends and seek overseas advancement strategies to foster the Korean bio industry.

In the forum, Joseph (Joe) P. McMenamin, an Executive Vice President and Chief Legal Officer with W Medical Strategy Group, was featured as a speaker in the panel discussion.

Here is the link youtube.com/watch?v=r0j_rMsaLJ4&feature=youtu.be

to the recorded video of the Global Bio Forum 2020.





November 25, 2020

9:00 AM – 16:00 PM (GMT +9)

Lotte Hotel Seoul, Emerald Rm (2F), Seoul, Korea

& Live on YouTube


Program

9:00-9:30 AM Opening Ceremony


Baik Kyu Lee, CEO, News1

Gang Lip Kim, Minister, Ministry of Food and Drug Safety

Byung Seon Jeong, 1st Vice-Minister, Ministry of Science and ICT

BG Rhee, Chairman, News1 Bioleader’s club; Chairman, Council for Advanced Regenerative Medicine; CEO, SCM Lifescience


9:30-10:15 AM Keynote Speech

Seeking Opportunities in Risk, K-Bio in the World Pandemics


Jung Jin Seo, Chairman, Celltrion Group


10:15-10:45 AM Session 1

Covid Vaccines: Approaching the End of Beginning


David Flores, BioCentury President & CEO



10:45-11:30 AM Discussion

The Possibility of Success in Developing COVID-19 Vaccine and Treatment Worldwide – Behind Stories of Pfizer and Moderna


David Flores, BioCentury President & CEO

Cameron Wolfe, Associate Professor, Duke University

Joseph P. McMenamin, Executive Vice President,

W Medical Strategy Group

Andy Jang, Co-founder & CEO, Starassets Investment


11:30-12:00 PM IR Session

Covid-19 Cure & Vaccine


GC Greencross (Plasma therapy)

Ybiologics (Antibody)


12:00-12:30 PM Session 2

Hepatitis C – the Story of Developing a Cure


Dimitry Semizarov, Director, Global Medical Affairs Hepatology, Abbvie

Matthew Krzywosz, Associate Scientific Director, Global Medical Affairs Hepatology, Abbvie



12:30-13:30 PM Lunch

13:30-14:00 PM Session 3

CRO-CDO-CMO: End to End Service Provider


Wan Goo Hwang, Managing Director, Samsung Biologics


14:00-14:30 PM IR Session

Covid-19 Diagnosis


Optolane (Diagnostic kit)

PCL (Diagnostic kit)



14:30-14:40 PM Coffee Break



14:40-15:55 PM IR Session

Cancer & Orphan Drug


Genome & Company

HaplnScience

Tiumbio

Toolgen

Abionbio